Top Page
Delta Drone International Ltd
(Sydney:RKT)
Delta Drone International Ltd (RKT) vs. iShares MSCI Australia ETF (EWA)
Delta Drone International Ltd Business Overview & Revenue Model
Delta Drone International Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.09M | 7.24M | 6.14M | 5.73M | 4.58M |
| Gross Profit | 2.94M | 3.64M | 3.13M | 2.80M | 2.43M |
| EBITDA | -1.47M | -1.03M | -1.43M | -1.98M | -1.63M |
| Net Income | -2.32M | -1.92M | -1.77M | -1.92M | -3.62M |
Balance Sheet | |||||
| Total Assets | 8.10M | 8.35M | 6.81M | 6.97M | 10.28M |
| Cash, Cash Equivalents and Short-Term Investments | 1.74M | 3.45M | 2.38M | 2.31M | 989.78K |
| Total Debt | 1.70M | 1.34M | 1.17M | 380.78K | 733.04K |
| Total Liabilities | 3.12M | 2.50M | 2.18M | 1.32M | 3.55M |
| Stockholders Equity | 5.26M | 6.18M | 4.92M | 5.59M | 8.04M |
Cash Flow | |||||
| Free Cash Flow | -2.80M | -1.73M | -1.90M | -2.34M | -2.43M |
| Operating Cash Flow | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -1.99M | -1.16M | -56.51K | 3.25M | -498.27K |
| Financing Cash Flow | 3.23M | 2.72M | 1.12M | -355.46K | -165.27K |
Delta Drone International Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | AU$27.20M | -1.97 | -40.51% | ― | ― | ― | |
50 Neutral | AU$16.42M | 0.92 | 26.81% | ― | -21.60% | -657.00% | |
48 Neutral | AU$9.29M | -13.48 | -119.80% | ― | 106.54% | 74.33% | |
46 Neutral | AU$11.77M | -16.86 | -2.67% | ― | 24.43% | 40.63% | |
43 Neutral | AU$6.44M | -3.48 | -658.94% | ― | 13.07% | 68.60% |
Delta Drone International Ltd Corporate Events
RocketDNA Ltd has launched its proprietary Skylink operating system platform into an initial live testing phase with an existing Tier-1 global mining customer, marking a key step in scaling its remote drone operations. The Skylink OS provides a centralised mission request and management interface that allows enterprise users to draw mission areas, set priorities, and track real-time status, enabling on-demand or scheduled autonomous drone flights for consistent data delivery.
The platform is designed to improve operational transparency and efficiency for large enterprise deployments, while also integrating with RocketDNA’s SiteTube product to offer an end-to-end workflow from data request to visualisation. RocketDNA expects Skylink to evolve through staged upgrades toward deeper automation, broader third-party integrations, and multi-site, one-to-many drone operations, positioning the company to enhance service levels and refine the product in collaboration with Tier-1 customers ahead of a wider commercial rollout.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Limited is an ASX-listed company that has lodged its corporate governance documentation for the financial year ended 31 December 2025. The company operates under the ASX Corporate Governance Council’s Principles and Recommendations, with governance materials made available through its website to inform shareholders and market participants about its board and management frameworks.
RocketDNA has confirmed that its corporate governance statement is current as of 25 February 2026 and has been approved by the board, including Chairman David Morton. The company has lodged an Appendix 4G with the ASX, outlining compliance with key governance recommendations such as maintaining a board charter, conducting due diligence on directors and executives, and formalising written agreements with senior leadership.
The governance statement details how RocketDNA delineates roles between the board and management and ensures the company secretary reports directly to the board through the chair. By publicly disclosing these structures and confirming adherence to ASX rules, RocketDNA aims to strengthen transparency, meet regulatory expectations, and give stakeholders greater visibility into its oversight and decision-making processes.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Limited has released an updated corporate governance statement, confirming that its board remains responsible for overseeing the company’s management and safeguarding shareholder interests. The board has adopted the ASX Corporate Governance Council’s Fourth Edition principles where practical, while acknowledging that full compliance may not always be optimal given the company’s scale and circumstances.
The statement details the company’s adherence to key governance measures, including a formal board charter, rigorous checks for director and executive appointments, and written agreements for all senior leaders. RocketDNA also outlines the central role of its company secretary and maintains a diversity policy framework, signalling a continued focus on robust governance structures as a foundation for future growth and stakeholder confidence.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd reported a modest 6% rise in revenue to $7.683 million for the year to 31 December 2025, but its net loss attributable to members widened to $2.815 million, a 46% deterioration from the prior year. The company did not declare any dividends, with net tangible assets edging up slightly to 0.52 cents per share, suggesting continued capital intensity and a focus on reinvestment rather than shareholder payouts.
The absence of acquisitions, divestments, associates or joint ventures during the period indicates that RocketDNA’s performance was driven largely by its existing operations rather than structural changes. Investors seeking deeper insight into the drivers of the higher loss and operational trends will need to rely on the accompanying directors’ report and full financial statements, as the company provided limited commentary in the headline figures.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has notified the market of the issue of 5,000,000 unquoted options under ASX code RKTAB, each exercisable at $0.02 and expiring on 30 May 2029, with an issue date of 19 January 2026. The new options, which are not intended to be quoted on the ASX, form part of a previously announced transaction and signal ongoing use of equity-based instruments in the company’s capital management and incentive structures, with potential future dilution for existing shareholders depending on exercise.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has detailed the terms and conditions of 5,000,000 consultant options previously notified as a proposed issue of securities, each option carrying an exercise price of $0.02 and expiring on 30 May 2029. The options vest on 1 July 2026 subject to the holder’s continued engagement with the group, are exercisable at any time up to expiry, and upon exercise will convert into fully paid ordinary shares ranking equally with existing shares, underscoring the company’s use of equity-based incentives to align consultants with its long-term growth objectives.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd., listed on the ASX under the code RKT, has lodged a notice with the exchange outlining a proposed issue of new securities via a placement or similar capital-raising mechanism. The company did not include additional operational or strategic details about its business activities in the filing.
RocketDNA plans to issue up to 5 million options (ASX code RKTAB), each with an exercise price of $0.02 and an expiry date of 30 May 2029, with a proposed issue date of 19 January 2026. The move signals an intention to bolster its capital structure through option-based financing, potentially providing future funding flexibility and aligning investor participation with the company’s longer-term share price performance.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has announced that a performance milestone has been met, triggering the vesting of 4 million 2025 Performance Rights held by Managing Director Chris Clark and 2 million held by executive director Paul Williamson. The milestone was achieved after the company reached a 30-day volume-weighted average price of A$0.02 for its shares within the specified assessment period, and each vested right can now be exercised into one fully paid ordinary share for nil consideration before 30 September 2026, potentially increasing the company’s share count and further aligning executive incentives with shareholder value.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has issued 617,984 fully paid ordinary shares to employees under its Employee Incentive Plan, expanding its share capital without undertaking a formal prospectus or disclosure process under Part 6D.2 of the Corporations Act. The company confirmed it remains compliant with its financial reporting and continuous disclosure obligations and stated there is no excluded information that would be material to investors’ assessment of RocketDNA’s financial position or the rights attached to its securities, signaling that the issuance is an administrative step in employee compensation rather than a move tied to undisclosed developments.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has notified the market of the issuance of 4.5 million unquoted performance rights to employees under its 2025 employee incentive scheme, effective 7 January 2026. The move underscores the company’s use of equity-based remuneration to attract and retain key staff, aligning employee incentives with shareholder interests and signalling ongoing investment in human capital to support its growth and operational objectives.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd. has applied to the ASX for quotation of 617,984 new fully paid ordinary shares, issued on 7 January 2026 under its employee incentive plan approved by shareholders in May 2024. The move modestly increases the company’s quoted capital base and underscores its continued use of equity-based remuneration to attract and retain staff, aligning employees’ interests with those of shareholders and signalling an ongoing commitment to incentivising key talent in a competitive technology sector.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has announced that a performance milestone has been met, triggering the full vesting of 3,000,000 performance rights held by Managing Director and CEO Chris Clark and 1,500,000 performance rights held by executive director Paul Williamson. The vesting was tied to the company achieving a total shareholder return of 100%, reflected in the rise of the 10-day volume-weighted average share price from $0.0106 at issuance of the 2023 performance rights to $0.0235 as at 2 January 2026, and each right can now be exercised into one fully paid ordinary share at no cost before 29 May 2027, signalling both a significant uplift in shareholder value and the realisation of executive long-term incentive targets.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
Pither Investments Pty Ltd and Nintieth Y Pty Ltd have ceased to be substantial shareholders in Rocketdna Ltd, as disclosed in a statutory notice lodged under the Corporations Act. The change, effective 24 December 2025 and attributed to dilution and trading, reduces their voting influence in the company and signals a shift in Rocketdna’s share register that existing and prospective investors may factor into their assessment of the stock’s ownership dynamics.
RocketDNA Ltd has disclosed a change in the holdings of director Paul Williamson, who acquired 1,333,333 ordinary fully paid shares on 24 December 2025 through participation in the second tranche of a shareholder-approved placement. Following the $20,000 on-market investment, Williamson’s direct holding increased to 7,273,503 ordinary shares, alongside his existing 12 million performance rights and 15 million options with staggered expiries to 2031, signalling continued director support for the company’s capital-raising efforts and long-term strategy.
RocketDNA Ltd has disclosed a change in director David Morton’s indirect interest in the company’s securities, as required under ASX listing rules. Through an associated holder, Morton acquired 6,666,666 additional ordinary fully paid shares on 24 December 2025 for a consideration of $100,000, increasing his indirect shareholding in RocketDNA. The notice formalises the transaction for regulatory transparency and signals a further financial commitment by a board member, which may be interpreted by investors as a vote of confidence in the company’s prospects.
RocketDNA Ltd has disclosed a change in the interests of director Chris Clark, whose holdings are held indirectly via C & K Clark SMSF Pty Ltd. Clark acquired 666,666 additional ordinary fully paid shares for $10,000 through participation in tranche two of a previously approved placement, increasing his indirect shareholding while leaving his existing performance rights and options unchanged. The transaction, endorsed by shareholders at a general meeting on 18 December 2025, modestly strengthens insider ownership and signals continued board-level support for the company’s capital-raising activities and strategic direction.
RocketDNA Ltd has issued 45,199,993 new ordinary fully paid shares at $0.015 per share as part of a placement previously announced to the market and approved by shareholders at a recent general meeting. The company confirmed that the shares were issued without a prospectus under the relevant exemption in the Corporations Act, that it remains compliant with its financial reporting and continuous disclosure obligations, and that there is no excluded information that investors would reasonably require, underscoring regulatory compliance and transparency around the capital raising for existing and prospective shareholders.
RocketDNA Ltd has applied to the ASX for quotation of 45,199,993 new fully paid ordinary shares under code RKT, following the issue of these securities on 24 December 2025. The move expands the company’s quoted capital base and formalises the trading status of shares previously flagged to the market, potentially enhancing liquidity for existing investors and supporting RocketDNA’s capacity to pursue future corporate and operational initiatives.
RocketDNA Ltd has invited shareholders and interested investors to an online webinar on 23 December 2025, where Managing Director and CEO Christopher Clark will brief the market on recent operational progress and customer activity. The session will cover new contracts and purchase orders, the company’s first deployment into BHP’s iron ore operations, expansion across existing clients in Australia and Africa, progress in scaling its autonomous drone services and software, and near-term operational priorities heading into 2026, offering investors additional context on growth opportunities and the company’s evolving market position.
RocketDNA Ltd announced the successful passage of all resolutions at its General Meeting held on December 18, 2025. The resolutions, including the ratification and approval of recent share placements, signal stakeholder confidence and provide the necessary financial flexibility to support RocketDNA’s strategic growth initiatives. These measures are important for maintaining the company’s competitive edge in its core industries and markets.
RocketDNA Ltd has secured approximately A$1 million in new orders from existing clients, reflecting a growing demand for their autonomous drone solutions in the mining sector. The company has expanded its xBot deployments across Australia and secured contracts with major mining companies such as BHP and Assmang, enhancing their market presence and operational capabilities. These developments indicate RocketDNA’s strong positioning to meet increasing industry demand for automation and safety improvements, with plans to further develop their software offerings to support long-term growth.